⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIOA News
BioAge Labs, Inc. Common Stock
BioAge Labs to Present at Piper Sandler 37th Annual Healthcare Conference
globenewswire.com
BIOA
BioAge Labs to Present at Jefferies Global Healthcare Conference in London
globenewswire.com
BIOA
HitGen Partner BioAge Labs Initiates Phase 1 Clinical Study of BGE-102, a Novel Brain-Penetrant NLRP3 inhibitor
prnewswire.com
BIOA